Watch Out Sanofi! Chinese Fast-Follower Emerges With Dupixent Rival

Promising Top-Line Data

 
• By Dexter Jie Yan
  
fast followers
Keymed's stapokibart is closing in on Dupixent in the atopic dermatitis space in China • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia